| 000 | 01650 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515080647.0 | ||
| 264 | 0 | _c20080125 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0385-5600 | ||
| 024 | 7 |
_a10.1111/j.1348-0421.2007.tb03963.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKinjo, Takeshi | |
| 245 | 0 | 0 |
_aAdjuvant effect of CpG-oligodeoxynucleotide in anti-fungal chemotherapy against fatal infection with Cryptococcus neoformans in mice. _h[electronic resource] |
| 260 |
_bMicrobiology and immunology _c2007 |
||
| 300 |
_a741-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Pharmaceutic _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xmicrobiology |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCryptococcosis _xdrug therapy |
| 650 | 0 | 4 |
_aCryptococcus neoformans _xgrowth & development |
| 650 | 0 | 4 |
_aCytokines _ximmunology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aFluconazole _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xmicrobiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xpharmacology |
| 650 | 0 | 4 |
_aTh1 Cells _ximmunology |
| 700 | 1 | _aMiyagi, Kazuya | |
| 700 | 1 | _aNakamura, Kiwamu | |
| 700 | 1 | _aHiga, Futoshi | |
| 700 | 1 | _aGang, Xiao | |
| 700 | 1 | _aMiyazato, Akiko | |
| 700 | 1 | _aKaku, Mitsuo | |
| 700 | 1 | _aFujita, Jiro | |
| 700 | 1 | _aKawakami, Kazuyoshi | |
| 773 | 0 |
_tMicrobiology and immunology _gvol. 51 _gno. 8 _gp. 741-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1348-0421.2007.tb03963.x _zAvailable from publisher's website |
| 999 |
_c17235783 _d17235783 |
||